Molecular-based diagnosis of Clostridium difficile infection is associated with reduced mortality
- 7 April 2018
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 37 (6) , 1137-1142
Abstract
Polymerase chain reaction (PCR) for the diagnosis of Clostridium difficile infection (CDI) might result in overdiagnosis. The clinical outcomes of symptomatic CDI patients diagnosed by PCR remain uncertain. We aimed to determine whether patients whose diagnosis of CDI was based on PCR had different characteristics and clinical outcomes than those diagnosed by toxin immunoassay. Consecutive CDI patients, hospitalized at Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel, between January 2013 and January 2016, were identified retrospectively and included in the study. Diagnosis of CDI was based on PCR or diagnosis by immunoassay for C. difficile toxin. The main outcome was 30- and 90-day all-cause mortality. The PCR group included 165 patients and the immunoassay group included 157 patients. In comparison to the immunoassay group, patients in the PCR group were more likely to be younger, to be independent, to undergo previous abdominal surgery, and to use laxatives. The 30-day mortality rate in the PCR group was significantly lower than that in the immunoassay group, 29/165 (18%) vs 49/157 (31%), respectively; p = 0.028. On multivariate analysis, PCR diagnosis was associated with reduced mortality, OR 0.48 (95% CI 0.26–0.88). PCR-based diagnosis of CDI is associated with reduced all-cause mortality rates. Further studies are needed to determine the management of patients with discrepant immunoassay and PCR diagnosis of CDI.Keywords
This publication has 14 references indexed in Scilit:
- The Role of Glutamate Dehydrogenase (GDH) Testing Assay in the Diagnosis of Clostridium difficile Infections: A High Sensitive Screening Test and an Essential Step in the Proposed Laboratory Diagnosis Workflow for Developing Countries like ChinaPLOS ONE, 2015
- Overdiagnosis ofClostridium difficileInfection in the Molecular Test EraJAMA Internal Medicine, 2015
- Changes in the incidence of health care–associated pathogens at a university hospital from 2005 to 2011American Journal of Infection Control, 2014
- Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infectionThe Lancet Infectious Diseases, 2013
- Impact of the Type of Diagnostic Assay on Clostridium difficile Infection and Complication Rates in a Mandatory Reporting ProgramClinical Infectious Diseases, 2012
- Nosocomial Diarrhea: Evaluation and Treatment of Causes Other Than Clostridium difficileClinical Infectious Diseases, 2012
- Clinical and Laboratory Characteristics of Clostridium difficile Infection in Patients with Discordant Diagnostic Test ResultsJournal of Clinical Microbiology, 2012
- Clinical and Infection Control Implications of Clostridium difficile Infection With Negative Enzyme Immunoassay for ToxinClinical Infectious Diseases, 2011
- Evaluation of Diagnostic Tests for Clostridium difficile InfectionJournal of Clinical Microbiology, 2010
- Increase in AdultClostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005Emerging Infectious Diseases, 2008